Form 8-K - Current report:
SEC Accession No. 0000950170-22-018857
Filing Date
2022-09-26
Accepted
2022-09-26 17:00:36
Documents
13
Period of Report
2022-09-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crbp-20220920.htm   iXBRL 8-K 66950
2 EX-99.1 crbp-ex99_1.htm EX-99.1 13511
  Complete submission text file 0000950170-22-018857.txt   200457

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crbp-20220920_pre.xml EX-101.PRE 9453
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crbp-20220920_lab.xml EX-101.LAB 12806
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crbp-20220920.xsd EX-101.SCH 2469
7 EXTRACTED XBRL INSTANCE DOCUMENT crbp-20220920_htm.xml XML 4539
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

EIN.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37348 | Film No.: 221266470
SIC: 2834 Pharmaceutical Preparations